Skyland Trail Participating in Three Research Studies

A hallmark of the Skyland Trail treatment program is individualized, evidence-based care. Each person experiences mental health disorders differently. And treatments that are effective for some are less effective for others. More research is needed to help identify the best treatments for individuals based on biological and environmental factors.

Skyland Trail is currently participating in three research studies.

  • Improving Sleep and Cognition for Adult Patients with Depression: Sumitomo Pharma/University of Miami

    Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Benefits: Comparison of Patients treated with Lurasidone vs. Patients with Major Depression Receiving SSRI Treatment as Usual

    This study will examine the impact of Lurasidone on sleep and gains in cognitive training compared to those on depression medication to determine if there are benefits to the use of Lurasidone in these areas.
     
  • Understanding the Role of Hormones for Adult Female Patients with Borderline Personality Disorder: Emory University School of Medicine Department of Gynecology and Obstetrics

    Ovarian Hormones and Borderline Personality Disorder: A Prospective Study of Females Undergoing Residential Treatment

    This study will examine circulating ovarian hormones to determine how they map on to symptoms, symptom severity, and treatment response so that we can develop more personalized treatment approaches.
     
  • Understanding the Unique Needs of LGBTQ+ Teens in Psychiatric Treatment Programs: Georgia Clinical Translational Science Alliance; Emory University School of Medicine Department of Gynecology and Obstetrics

    Establishing Community-Based Participatory Research Direction in LGBTQ + Adolescents Receiving Intensive Psychiatric Care

    This study will collect data through surveys and focus groups of parents of previous adolescent patients. The goal is to engage this community to assess comfort with research in the context of treatment, goals for research, and perceived areas of priority. Importantly, this study will focus on understanding the different challenges and needs of parents of LGBTQ+ and non-LGBTQ+ patients.